Mechanistically, STAT3 deletion lowers the levels of cell cycle mediators (c-MYC, cyclin D1, and cyclin E) and survival proteins (Bcl-xL) in tumor cells [120, 435]. This evidence concerns the gene STAT3 and neoplasm.